Modeling xeroderma pigmentosum associated neurological pathologies with patients-derived iPSCs

Abstract

Xeroderma pigmentosum (XP) is a group of genetic disorders caused by mutations of XP-associated genes, resulting in impairment of DNA repair. XP patients frequently exhibit neurological degeneration, but the underlying mechanism is unknown, in part due to lack of proper disease models. Here, we generated patientspecific induced pluripotent stem cells (iPSCs) harboring mutations in five different XP genes including XPA, XPB, XPC, XPG, and XPV. These iPSCs were further differentiated to neural cells, and their susceptibility to DNA damage stress was investigated. Mutation of XPA in either neural stem cells (NSCs) or neurons resulted in severe DNA damage repair defects, and these neural cells with mutant XPA were hyper-sensitive to DNA damage-induced apoptosis. Thus, XP-mutant neural cells represent valuable tools to clarify the molecular mechanisms of neurological abnormalities in the XP patients.

Keywords

xeroderma pigmentosum / iPSC / disease model / neural stem cell / neuron

References

[1] Andrade LND (2012) Evidence for premature aging due to oxidative stress in iPSCs from Cockayne syndrome . Hum Mol Genet 21(17):3825–3834

[2] Andressoo JO (2009) An Xpb mouse model for combined Xeroderma pigmentosum and cockayne syndrome reveals progeroid features upon further attenuation of DNA repair . Mol Cell Biol 29(5):1276–1290

[3] Anttinen A(2008) Neurological symptoms and natural courseof xeroderma pigmentosum . Brain 131:1979–1989

[4] Cattoglio C (2015) Functional and mechanistic studiesof XPC DNA-repair complex as transcriptional coactivator in embryonic stem cells . Proc Natl Acad Sci USA 112(18):E2317–E2326

[5] Cheung HH (2014) Telomerase protects werner syndrome lineage-specific stem cells from premature aging . Stem Cell Reports 2(4):534–546

[6] Chou KM (2011) DNA polymerase eta and chemotherapeutic agents . Antioxid Redox Signal 14(12):2521–2529

[7] Cleaver JE (1968) Defective repair replication of DNA in xeroderma pigmentosum . Nature 218(5142):652–656

[8] Cleaver JE (1972) Xeroderma pigmentosum—variants with normal DNA-repair and normal sensitivity to ultraviolet-light . J Investig Dermatol 58(3):124–128

[9] Cleaver JE, Lam ET, Revet I(2009) Disordersof nucleotide excision repair: the genetic and molecular basis of heterogeneity . Nat Rev Genet 10(11):756–768

[10] De Weerd-Kastelein EA, Bootsma D, Keijzer W (1972) Genetic heterogeneity of Xeroderma pigmentosum demonstrated by somatic cell hybridization . Nature 238(81):80–83

[11] Ding Z (2015) A widely adaptable approach to generate integration-free iPSCs from non-invasively acquired human somatic cells . Protein Cell 6(5):386–389

[12] Duan S (2015) PTENdeficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype . Nat Commun 6:10068

[13] Epstein JH (1970) Defect in DNA synthesis in skin of patients with xeroderma pigmentosum demonstratedin vivo . Science 168 (3938):1477–1478

[14] Fassihi H(2013) Spotlight on ‘xeroderma pigmentosum’ . Photochem Photobiol Sci 12(1):78–84

[15] Grewal RP (1991) Neurons and DNA-Repair-Neurologic Involvement in Xeroderma Pigmentosa . Med Hypotheses 34(2):171–173

[16] Hayashi M (2004) Brainstem and basal ganglia lesions in xeroderma pigmentosum group A . J Neuropathol Exp Neurol 63 (10):1048–1057

[17] Khan SG (2004) Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk . Hum Mol Genet 13(3):343–352

[18] Kulkarni A, Wilson DM (2008) The involvement of DNA-damage and-repair defects in neurological dysfunction . Am J Hum Genet 82 (3):539–566

[19] Lai JP (2013) The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D) . Acta Neuropathol Commun 1:4

[20] Liu GH (2011a)Recapitulation of prematureageing with iPSCs from Hutchinson-Gilford progeria syndrome . Nature 472(7342):221–225

[21] Liu GH (2011b) Targeted gene correction of laminopathyassociated LMNA mutations in patient-specific iPSCs . Cell Stem Cell 8(6):688–694

[22] Liu GH (2012) Progressive degeneration of human neural stem cells caused by pathogenic LRRK2 . Nature 491(7425):603–607

[23] Liu GH (2014) Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs . Nat Commun 5:4330

[24] Maeda T (1994) Severe neurological abnormalities associated with a mutation in the zinc-finger domainina groupA Xeroderma pigmentosum patient . BrJ Dermatol 131(4):566–570

[25] Masutani C(1999) The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta . Nature 399(6737): 700–704

[26] Mocquet V (2008) Sequential recruitment of the repair factors during NER: the role of XPG in initiating the resynthesis step . EMBOJ 27(1):155–167

[27] Muller LUW (2012) Overcoming reprogramming resistance of Fanconi anemia cells . Blood 119(23):5449–5457

[28] Nakagawa A (1998) Three-dimensional visualization of ultraviolet-induced DNA damage and its repair in human cell nuclei . Journal of Investigative Dermatology 110(2):143–148

[29] Nakane H (1995) High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumoursin mice lacking the Xeroderma pigmentosum groupA gene . Nature 377(6545):165–168

[30] Okita K(2011)A moreefficient method to generate integration-free human iPS cells . Nat Methods 8(5):409–412

[31] Raya A (2009) Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells . Nature 460 (7251):U53–U61

[32] Robbins JH (1974) Xeroderma pigmentosum: an inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair . Ann Intern Med 80(2):221–248

[33] Scharer OD (2013) Nucleotide excision repair in eukaryotes . Cold Spring Harb Perspect Biol 5(10):a012609

[34] Setlow RB, Setlow JK (1962) Evidence that ultraviolet-induced thymine dimers in DNA cause biological damage . Proc Natl Acad Sci USA 48(7):1250

[35] Shimamoto A (2014) Reprogramming suppresses premature senescence phenotypes of Werner syndrome cells and maintains chromosomal stability over long-term culture . PLoS ONE 9(11): e112900

[36] Suzuki K (2014) Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones . Cell Stem Cell 15(1):31–36

[37] Xu XL (2014) Direct reprogramming of porcine fibroblasts to neural progenitor cells . Protein Cell 5(1):4–7

[38] Yung SK (2013) Brief report: human pluripotent stem cell models of fanconi anemia deficiency reveal an important role for fanconi anemia proteins in cellular reprogramming and survival of hematopoietic progenitors . Stem Cells 31(5):1022–1029

[39] Zhang WQ (2015)AWerner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging . Science 348(6239):1160–1168

RIGHTS & PERMISSIONS

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.